Inventor · disambiguated record
Bonnie Chandler Abbruzzese
Also filed as: ABBRUZZESE BONNIE C · ABBRUZZESE BONNIE CHANDLER
9 granted patents·5 pending applications·477 citations·filing 1993–2020
92Inventor score
Top patents by PatentIndex Score
14 records- 0197US6326355B1Method for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 2000·Granted Dec 4, 2001·134 cites·13 claims
- 0294US6387883B1Method for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 2000·Granted May 14, 2002·45 cites·18 claims
- 0391US6077828AMethod for the prevention and treatment of cachexia and anorexiaABBOTT LAB·Filed 1997·Granted Jun 20, 2000·67 cites·20 claims
- 0483US5547927AEnteral nutritional product for patients undergoing radiation therapy and/or chemotherapyABBOTT LAB·Filed 1993·Granted Aug 20, 1996·51 cites·19 claims
- 0579US5700782AEnteral nutritional productABBOTT LAB·Filed 1995·Granted Dec 23, 1997·71 cites·19 claims
- 0677US5514656AMethod of providing enteral nutritional support for patients undergoing radiation therapy and/or chemotherapyABBOTT LAB·Filed 1993·Granted May 7, 1996·40 cites·19 claims
- 0776US5403826ANutritional product for persons infected with human immunodeficiency virusABBOTT LAB·Filed 1993·Granted Apr 4, 1995·36 cites·20 claims
- 0866US7223736B2Composition for the prevention and treatment of cachexiaABBOTT LAB·Filed 2004·Granted May 29, 2007·1 cites·6 claims
- 0966US5480872AMethod of providing enternal nutritional support to persons infected with human immunodeficiency virusABBOTT LAB·Filed 1993·Granted Jan 2, 1996·32 cites·20 claims
- 1063US2007196445A1Method for the Prevention and Treatment of Cachexia and AnorexiaABBRUZZESE BONNIE C·Filed 2007·Application pending·0 cites
- 1153US2020237937A1Compositions and methods for assessing macrophage mediated pathologyNAVIDEA BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1253US2002099020A1Method for the prevention and treatment of cachexia and anorexiaFiled 2001·Application pending·0 cites
- 1348US2019022259A1Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventionsNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1444US2019021608A1CD206+ Macrophage-Specific Molecular Imaging Probe Compositions and Methods and the Noninvasive Quantification of Arterial Wall Macrophage Infiltration in HumansNAVIDEA BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →